Specialty medication tolvaptan 15MG X7/ 45MG X7 dose PAK
Ended Awarded
- Contract number
- 36C24920F0473
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $20,069
Award facts
- Contract value 100% obligated
- $20,069.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 9, awarded a delivery order to Otsuka America Pharmaceutical Inc. on August 18, 2020, for specialty medication tolvaptan in dose-pack formulations (15mg and 45mg). The contract, valued at approximately $20,000, was executed as a firm fixed-price delivery order with no set-aside designation and a performance location in Potomac, Maryland. Tolvaptan, marketed under the brand name Jynarque, is utilized in the VA healthcare system to treat complex conditions including autosomal dominant polycystic kidney disease and hyponatremia, addressing specialized pharmaceutical needs for veterans across multiple integrated service networks.
This delivery order is issued under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and represents a task order against Otsuka America Pharmaceutical Inc.'s larger Blanket Purchase Agreement with the National Acquisition Center, which carries an $83.3 million ceiling value through March 2026. As a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, Otsuka America Pharmaceutical Inc. holds significant indefinite delivery vehicles with the VA and maintains established capabilities to supply specialty pharmaceuticals to federal healthcare systems. The contract supports the VA's mission to provide veterans with access to critical, specialized pharmaceutical treatments through streamlined procurement mechanisms.
Quick answers
Who was awarded contract 36C24920F0473?
36C24920F0473 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 9 (Veterans Health Administration) on August 18, 2020.
How much is contract 36C24920F0473 worth?
The government has obligated $20,069 on 36C24920F0473.
Is contract 36C24920F0473 an order under another contract?
Yes. 36C24920F0473 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24920F0473 competed?
The extent of competition for 36C24920F0473 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award